Primary Job Title CFO Primary Organization Engrail Therapeutics
Location San Diego, California, United States Regions Greater San Diego Area, West Coast, Western US Gender Male
LinkedIn View on LinkedIn
Mr. Cayer has served as Otonomy’s chief business officer since October 2008, chief financial officer since October 2010, and secretary since February 2011. He brings more than 25 years of experience in the pharmaceutical, medical device and healthcare technology field. Prior to joining our company, Mr. Cayer served from 2005 to 2008 as senior vice
president, corporate development for Verus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the treatment of allergic and respiratory disorders in children. From 2001 to 2005, Mr. Cayer served as the chief financial officer and senior vice president, business development of Targeted Molecules Corporation, a biopharmaceutical company.
Mr. Cayer has also held various management positions with Gensia Pharmaceuticals, Inc., a biopharmaceutical company, Acuson, a provider of medical ultrasound systems, Castle & Cooke, a consumer products company and served as consultant with Booz-Allen & Hamilton, a management and technology consulting firm. Mr. Cayer received his master’s degree in business and bachelor’s degree in biomechanical engineering from Harvard University.
